CLINICAL_TRIALS
trial_result
· 2010-07-14
Clinical Trial Update: Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia [Phase 3]
Summary
A Phase 3 extension study evaluating the safety of oral ziprasidone in adults with schizophrenia has completed with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2010-07-14